Cargando…
Should every patient with pancreatic cancer receive perioperative/neoadjuvant therapy?
Pancreatic ductal adenocarcinoma is a highly aggressive disease, and medical as well as surgical therapeutic options are limited. This article reviews stage dependent treatment options, with a special focus on the current controversy of perioperative treatment regimens in initially borderline resect...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5234154/ https://www.ncbi.nlm.nih.gov/pubmed/28144084 http://dx.doi.org/10.4103/0971-5851.195731 |